We speculate that the “watch and wait” strategy, adopted for SMA individuals with four or more SMN2 copies, may overshoot the most critical period when high SMN levels are required for NMJ development and maturation. This evidence concerns the gene STMN1 and proximal spinal muscular atrophy.